Post by Thermo Fisher Scientific

Today we announce a new collaboration with OpenAI to help customers run faster, smarter clinical trials and enable the delivery of new medicines to patients sooner. As Krishna Cheriath shares, pairing Thermo Fisher’s global scale and scientific expertise with OpenAI’s cutting-edge capabilities will help us tackle bottlenecks, reduce trial timelines, and deliver potentially life-changing medicines faster. Every day counts for patients waiting on new therapies. That’s why this work matters. Learn more at the link in the comments about the focus of this collaboration, which aims to accelerate innovation, enhance productivity and reduce complexity across critical areas of our business.

Video Content